14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.194 3 days ( 0 % )
Last Price $2.25 4.17 %
High/ Low $2.15 - $2.28 13.41%
Chg 7 Days 10.84 % $2.03 $2.25
Chg 30 Days 25.00 % $1.80 $2.25
Chg 12 mos -25.25 % $3.01 $2.25
Trend - 3 mos -34.22 % Width: 86.05 %
Trend - 12 mos 4.09 % Width: 313.70 %
Pred. range - 3 mos $0.782 - $1.46 -65.23 % - -35.30 %
Pred. range - 12 mos $1.48 - $6.14 -34.08 % - 172.71 %
Short MA avg 3 mos Buy May 10, 2024 - 6 days
Long MA avg 3 mos Buy May 09, 2024 - 7 days
Short/Long MA avg 3 mos Buy May 01, 2024 - 13 days
Short MA avg 12 mos Buy May 08, 2024 - 8 days
Long MA avg 12 mos Sell Jan 30, 2024 - 77 days
Short/Long MA avg 12 mos Sell Feb 12, 2024 - 68 days
Pivot Short Sell May 15, 2024 - 3 days
Bollinger Buy May 17, 2024 - 1 day
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals. Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bac... ACXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT